BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 3961453)

  • 1. [Quantitative liver function tests in porphyria cutanea tarda: improvement under therapeutic phlebotomy].
    Meister F; Reichen J
    Schweiz Med Wochenschr; 1986 Mar; 116(11):341-5. PubMed ID: 3961453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of treatment of porphyria cutanea tarda with bloodletting and chloroquine].
    Seubert S; Seubert A; Stella AM; Guzman H; Batlle A
    Z Hautkr; 1990 Mar; 65(3):223-5. PubMed ID: 2339575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the results of phlebotomy therapy and low-dose chloroquine treatment in porphyria cutanea tarda.
    Malina L; Chlumský J
    Acta Derm Venereol; 1981; 61(4):346-50. PubMed ID: 6173993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Porphyria cutanea tarda. Diagnosis, management, and differentiation from other hepatic porphyrias.
    Grossman ME; Poh-Fitzpatrick MB
    Dermatol Clin; 1986 Apr; 4(2):297-309. PubMed ID: 3955900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chloroquine in treatment of porphyria cutanea tarda. Long-term efficacy of combined phlebotomy and high-dose chloroquine therapy.
    Wennersten G; Ros AM
    Acta Derm Venereol Suppl (Stockh); 1982; 100():119-23. PubMed ID: 6962628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda.
    Felsher BF; Carpio NM; Engleking DW; Nunn AT
    N Engl J Med; 1982 Apr; 306(13):766-9. PubMed ID: 7062951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phlebotomy treatment of porphyria cutanea tarda.
    Lundvall O
    Acta Derm Venereol Suppl (Stockh); 1982; 100():107-18. PubMed ID: 6962627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of porphyria hepatica cutanea tarda by bloodletting (experience in 10 cases)].
    García Plaza A; España Saz P; Escartín Marín P; Diego Marín FJ; Criado Ortiz M
    Rev Clin Esp; 1973 Dec; 131(6):477-84. PubMed ID: 4780002
    [No Abstract]   [Full Text] [Related]  

  • 9. [Artefacts in porphyria cutanea tarda].
    Egger B; Goerz G
    Z Hautkr; 1990 Jun; 65(6):592, 595-6. PubMed ID: 2389593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porphyria cutanea tarda in association with hemosiderosis of the liver. Iron absorption studies and evaluation of therapy by phlebotomy.
    Strickland GT
    Am J Gastroenterol; 1968 Sep; 50(3):202-7. PubMed ID: 5677557
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combination therapy of porphyria cutanea tarda using chloroquine and bloodletting therapy].
    Horkay I; Nagy E
    Z Hautkr; 1980 Jun; 55(12):813-6. PubMed ID: 7415362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porphyria cutanea tarda. New facts on aetiology, pathogenesis clinical manifestations and treatment.
    Malina L; Chlumský J; Chlumská A
    Acta Univ Carol Med Monogr; 1974; (59):1-126. PubMed ID: 4616623
    [No Abstract]   [Full Text] [Related]  

  • 13. ACQUIRED PORPHYRIA CUTANEA TARDA: REPORT OF A CASE SUCCESSFULLY TREATED BY PHLEBOTOMY.
    KOVAL A; DANBY CW; PETERMANN H
    Can Med Assoc J; 1965 Sep; 93(10):537-40. PubMed ID: 14341652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinic and treatment of porphyria cutanea tarda (author's transl)].
    Goerz G
    Dermatologica; 1979; 159(5):393-9. PubMed ID: 488497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porphyria cutanea tarda: clinical and laboratory features.
    Sweeney GD; Jones KG
    Can Med Assoc J; 1979 Apr; 120(7):803-7. PubMed ID: 427687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The function and morphology of the liver in porphyria cutanea tarda.
    Ostrowski J; Michalak T; Zawirska B; Kostrzewska E; Błaszczyk M; Gregor A
    Ann Clin Res; 1984; 16(4):195-200. PubMed ID: 6508222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of porphyria cutanea tarda by venesection.
    Ramsay CA; Magnus IA; Turnbull A; Baker H
    Q J Med; 1974 Jan; 43(169):1-24. PubMed ID: 4822971
    [No Abstract]   [Full Text] [Related]  

  • 18. Porphyria cutanea tarda treated by repeated venesection: clinical and biochemical response.
    Baker H; Turnbull A
    Proc R Soc Med; 1969 Jun; 62(6):590-2. PubMed ID: 5802737
    [No Abstract]   [Full Text] [Related]  

  • 19. [Porphyrin metabolic disorders in porphyria cutanea tarda].
    Krivosheev BN
    Vestn Dermatol Venerol; 1989; (8):67-71. PubMed ID: 2816038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experiences with iron elimination therapy in porphyria cutanea tarda].
    Haneke E; Schwartze G
    Z Gesamte Inn Med; 1971 Nov; 26(22):710-6. PubMed ID: 5141034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.